Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S5
Novel NARS2 variants in a patient with early-onset status epilepticus: case study and literature review.
Yang N et al.
Bmc Pediatrics, 2024
38310242 (PubMed )
Supplement: 12887_2024_4553_MOESM1_ESM.xlsx › trio.hg38.filter
Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient.
Valentine H et al.
Cancer Research Communications, 2022
36643868 (PubMed )
Supplement: crc-22-0245-s07.xlsx › Variants_All_Exonic.exclude_ncR
Variants of ALPK1 with ABCG2, SLC2A9, and SLC22A12 increased the positive predictive value for gout.
Tu HP et al.
Journal of Human Genetics, 2018
URAT1 inhibition by ALPK1 is associated with uric acid homeostasis.
Kuo TM et al.
Rheumatology (oxford, England), 2017
Epidermal growth factor gene is a newly identified candidate gene for gout.
Han L et al.
Scientific Reports, 2016
Common variant of ALPK1 is not associated with gout: a replication study.
Chiba T et al.
Human Cell, 2015
ALPK1 genetic regulation and risk in relation to gout.
Ko AM et al.
International Journal of Epidemiology, 2013
Select a paper to view details